Market Highlights
It is estimated that the global extracorporeal membrane oxygenation machine market is expected to register a CAGR of 4.8 % during the forecast period of 2019 to 2025, with a market value of USD 267.60 million in 2018.
Extracorporeal membrane oxygenation machine is also known as a life support machine. It is used in the treatment of various heart and lung disease. The main function of extracorporeal membrane oxygenation machine is to provide enough oxygen to the body when heart and lung are not functioning properly. This machine is used in the treatment of lung cancer and various other chronic disorders. The extracorporeal membrane oxygenation machine market is driven by various factors such as increasing geriatric population, rising prevalence rates of lung cancer, and other chronic diseases.
Request Sample Copy:
https://www.marketresearchfuture.com/sample_request/8119
However, the high cost of surgery and increasing side effect after the treatment is expected to curb the growth of the extracorporeal membrane oxygenation machine market. The global extracorporeal membrane oxygenation machine market is currently dominated by several market players. The key players are involved in new product launches and strategic collaborations to strengthen its market position.
Regional Analysis
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The extracorporeal membrane oxygenation machine market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European extracorporeal membrane oxygenation machine market has been sub-divided Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, UK, Italy, Spain, and the rest of Western Europe. The extracorporeal membrane oxygenation machine market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The extracorporeal membrane oxygenation machine market in the Middle East & Africa has been divided into the Middle East and Africa.
Segmentation
The global extracorporeal membrane oxygenation machine market has been segmented based on component, modality, and application.
The market, based on component, has been divided into pumps, oxygenators, controllers, cannula, and accessories. The oxygenators segment is likely to hold a major share in the market due to the increasing adoption of extracorporeal membrane oxygenation machine for cardiac treatments. The pumps segment is predicted to be the fastest-growing due to the increasing incidences of asthma.
The market on the basis of modality is further segmented into veno-arterial (VA), veno-venous (VV), and arterio-venous (AV). The veno-arterial segment is expected to hold a major share in the market due to its widespread use in the treatment of cardiovascular collapse. Whereas veno-venous segment is expected to be the fastest-growing due to its increasing use in cardiogenic shock.
The market on the basis of application is further segmented into respiratory, cardiac, and extracorporeal cardiopulmonary resuscitation (ECPR). The respiratory segment is expected to hold the major share in the market due to its crucial role in supporting pulmonary function and is projected to witness lucrative growth over the forecast period whereas the extracorporeal cardiopulmonary resuscitation segment is expected to be the fastest-growing due to the rising incidence of cardiac illness worldwide.
Key Players
Some of the key players in the global extracorporeal membrane oxygenation machine market are Getinge Group, Medtronic, Livanova PLC, Abbott, Agilent Technologies, Siemens AG, Terumo Corporation, Fresenius Medical Care AG & Co. KGaA, Microport Scientific Corporation, Nipro Corporation, ALung Technologies, Inc., MAQUET Holding B.V. & Co. KG, Medos Medizintechnik AG, Terumo Cardiovascular Systems Corp, and Others.
Access Report Details @
https://www.marketresearchfuture.com/reports/extracorporeal-membrane-oxygenation-machine-market-8119
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
Extracorporeal Membrane Oxygenation Machine Market Research Report: Information by Component (Pumps, Oxygenators, Cannula and others), Modality, Application and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Global Forecast till 2027Market HighlightsIt is estimated that the global extracorporeal membrane oxygenation machine market is expected to register a CAGR of 4.8 % during the forecast period of 2019 to 2025, with a market value of USD 267.60 million in 2018.Extracorporeal membrane oxygenation machine is also known as a life support machine.
The main function of extracorporeal membrane oxygenation machine is to provide enough oxygen to the body when heart and lung are not functioning properly.
However, the high cost of surgery and increasing side effect after the treatment is expected to curb the growth of the extracorporeal membrane oxygenation machine market.The global extracorporeal membrane oxygenation machine market is currently dominated by several market players.
The key players are involved in new product launches and strategic collaborations to strengthen its market position.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8119SegmentationThe global extracorporeal membrane oxygenation machine market has been segmented based on component, modality, and application.The market, based on component, has been divided into pumps, oxygenators, controllers, cannula, and accessories.
The veno-arterial segment is expected to hold a major share in the market due to its widespread use in the treatment of cardiovascular collapse.
The respiratory segment is expected to hold the major share in the market due to its crucial role in supporting pulmonary function and is projected to witness lucrative growth over the forecast period whereas the extracorporeal cardiopulmonary resuscitation segment is expected to be the fastest-growing due to the rising incidence of cardiac illness worldwide.Key PlayersSome of the key players in the global extracorporeal membrane oxygenation machine market are Getinge Group, Medtronic, Livanova PLC, Abbott, Agilent Technologies, Siemens AG, Terumo Corporation, Fresenius Medical Care AG & Co. KGaA, Microport Scientific Corporation, Nipro Corporation, ALung Technologies, Inc., MAQUET Holding B.V. & Co. KG, Medos Medizintechnik AG, Terumo Cardiovascular Systems Corp, and Others.Regional AnalysisThe market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
Market HighlightsIt is estimated that the global extracorporeal membrane oxygenation machine market is expected to register a CAGR of 4.8 % during the forecast period of 2019 to 2025, with a market value of USD 267.60 million in 2018.Extracorporeal membrane oxygenation machine is also known as a life support machine.
The main function of extracorporeal membrane oxygenation machine is to provide enough oxygen to the body when heart and lung are not functioning properly.
However, the high cost of surgery and increasing side effect after the treatment is expected to curb the growth of the extracorporeal membrane oxygenation machine market.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/8119The global extracorporeal membrane oxygenation machine market is currently dominated by several market players.
The key players are involved in new product launches and strategic collaborations to strengthen its market position.SegmentationThe global extracorporeal membrane oxygenation machine market has been segmented based on component, modality, and application.The market, based on component, has been divided into pumps, oxygenators, controllers, cannula, and accessories.
The oxygenators segment is likely to hold a major share in the market due to the increasing adoption of extracorporeal membrane oxygenation machine for cardiac treatments.
The respiratory segment is expected to hold the major share in the market due to its crucial role in supporting pulmonary function and is projected to witness lucrative growth over the forecast period whereas the extracorporeal cardiopulmonary resuscitation segment is expected to be the fastest-growing due to the rising incidence of cardiac illness worldwide.Key PlayersSome of the key players in the global extracorporeal membrane oxygenation machine market are Getinge Group, Medtronic, Livanova PLC, Abbott, Agilent Technologies, Siemens AG, Terumo Corporation, Fresenius Medical Care AG & Co. KGaA, Microport Scientific Corporation, Nipro Corporation, ALung Technologies, Inc., MAQUET Holding B.V. & Co. KG, Medos Medizintechnik AG, Terumo Cardiovascular Systems Corp, and Others.Regional AnalysisThe market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Global Microvascular Anastomosis Market research report published by Reports and Data offers a comprehensive evaluation of the Microvascular Anastomosis market on the global scale and sheds light on the growth opportunities, prospects, and enables the readers to formulate strategic plans.
The report offers an in-depth analysis of the value chain, upstream and downstream factors, sales network and distribution channels, growth trends, driving and restraining factors, developments, production and consumption pattern, end-users, and regional segmentation.
The report also offers relevant and useful information to help the new entrants and established companies strengthen their market position.Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3173The report provides extensive coverage of the supply chain, key players of the industry, consumer base, company profiles, production and consumption rate, primary applications, and other relevant data.
It provides an in-depth assessment of the key companies operating in the market along with their company profiles, business overview, production and manufacturing capacity, product portfolio, financial standing, global position, and business expansion plans.
It also studies recent mergers and acquisitions, joint ventures, product launches, partnerships, collaborations, and agreements among other.
The report also provides insights into new entrants and their strategic alliances to gain a robust footing in the market.Key Manufacturers in the Global Microvascular Anastomosis Market:MedtronicBraunDextera Surgical Inc.Ethicon Inc.Vitalitec International Inc.Novare Surgical Systems, Inc.MAQUET Holding B.V. & Co.LivaNova PLCSynovis Micro Companies Alliance, Inc Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3173The report also provides an extensive regional segmentation to offer the readers key insights into the spread of the market over key geographical regions.
They are used in the surgical procedures that have the ability to exchange oxygen and carbon dioxide while the patient is undergoing a surgical procedures.
This is mainly owing to less hemolysis, less blood trauma and less bleeding.
In 2019, hospital held the largest share in the oxygenator market.
This is mainly owing to the improved patient safety and awareness among patients about health.
During cardiac surgery, the work of heat and lungs can be replaced by using oxygenator machine which is driving the growth of oxygenator market.
Oxygenator top 10 companies are LivaNova PLC, Medtronic, EUROSETS, Chalice Medical Ltd, MAQUET Holding B.V. & Co.
According to Extracorporeal Membrane Oxygenation Machine Market 2020 Global Industry Analysis To 2025, report on “Global Extracorporeal Membrane Oxygenation Machine Industry” published by Market Research Future, The Global Extracorporeal Membrane Oxygenation Machine Market expected to rise at highest CAGR by 2025.Extracorporeal Membrane Oxygenation Machine Market Analysis The global extracorporeal membrane oxygenation machine market was valued at USD 267.60 million in 2018 and is likely to grow at a 4.8% CAGR between 2019- 2025, as per the recent report by Market Research Future (MRFR).
Extracorporeal membrane oxygenation machine or the life support machine is used to treat various lung and heart disease.
Read more news on: https://www.medgadget.com/2019/10/extracorporeal-membrane-oxygenation-machine-ecmo-market-research-report-by-technology-top-manufactures-size-share-trend-growth-regional-highlights-analysis-by-2019-to-2023.htmlVarious factors are adding to the extracorporeal membrane oxygenation machine market growth.
According to the new MRFR report, such factors include increasing cases of lung cancer & other chronic diseases, rising geriatric population, growing prevalence of cardiovascular diseases, increasing use of ECMO, technological advances, and increasing awareness programs.
On the contrary, increasing side effects post treatment, technical failures, scarcity of skilled professionals, and high surgery costs are factors that may limit the extracorporeal membrane oxygenation machine market growth over the forecast period.
Extracorporeal Membrane Oxygenation Machine Market Segmentation The MRFR report offers an inclusive segmental analysis of the global extracorporeal membrane oxygenation machine market report based on application, modality, and component.
Increasing incidences of cardiovascular disorders leads to surge in demand for EVH.
According to WHO, globally CVD is the leading cause of death.
In addition, there is a rising prevalence of the risk associated with CVD including obesity, diabetes mellitus, and high blood pressure, which is further expected to boost demand for these devices.Technological advancements pertaining to cardiovascular medical devices is one of the pivotal factors anticipated to propel the growth of the EVH systems.
For instance, Maquet Cardiovascular LLC launched advanced VASOVIEW Technology for Endoscopic Vessel procedures in Cardiac Surgery.
In addition, increasing R activities with surging number of new product launches is one of the factor that expected to impel the market growth over forecast period.Request Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/endoscopic-vessel-harvesting-evh-system-market/request-sampleGrowing preferance for minimally invasive procedures and cost efficient surgeries is further boosts demand for EVH systems.
The reusable segment held the majority of the revenue share and was valued at USD 1,242.4 million in 2016.
